The Allocation of the Economic Value of Second-generation Antipsychotics Over the Product Life-cycle: the Case of Risperidone in Sweden and the UK
Berdud M, Wallin-Bernhardsson N, Zamora B, Lindgren P, Towse A
Value in Health 2023; 26(3): 328-335
DOI: https://doi.org/10.1016/j.jval.2022.11.022
